Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
130.00    -1.00 (-0.76%)
Bid:
127.50
Ask:
130.00
Spread: 2.50 (1.961%)
Market Cap: £207.12m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Pre-close Trading Update

31 Mar 2014 07:00

RNS Number : 5433D
Redcentric PLC
31 March 2014
 



31 March 2014

 

Redcentric plc

 

("Redcentric" or "the Group")

 

Pre-close Trading Update

 

Redcentric plc (AIM:RCN), a leading UK IT managed services provider announces a pre-close trading update. The Group expects to report its preliminary results for the financial year ended 31 March 2014 on 16 June 2014. 

Summary

· Trading comfortably in line with market expectations

· Recent contract wins and pipeline underpin positive outlook for FY 2015

· Strong Q4 cash flow

· Integration of inTechnology is on plan

· Intention to pay maiden dividend re-affirmed

Trading

Trading across the Group has continued to be in line with the Board's expectations and consequently Redcentric expects its results for the year ended 31 March 2014 to be comfortably in line with market expectations. The Group enters its new financial year with a good pipeline of new business opportunities underpinned by recent contract wins.

The Board has been pleased to see sustained improvements in operating cash flow conversion from the first half of the year following the expected unwind of working capital in the Redcentric business. Redcentric currently anticipates that net debt at the year-end will be in the region of £12.5 million and is expected to reduce significantly during 2014.

Integration

Redcentric remains on target to realise the synergies anticipated at the time of the acquisition of inTechnology Managed Services ("inTechnology"). The integration of the two businesses is progressing as planned as the Group seeks to combine all of its operations. A group operating board has been established across Sales, Operations and Finance and the integration programme will continue through FY2015 although the accounting and billing functions should be unified within the first half of the year.

Dividend

The Group reaffirms its intention to declare a maiden dividend with its results for the year ended 31 March 2014 marking the start of a progressive dividend policy.

Outlook

The acquisition of inTechnology is delivering the benefits that we expected. An encouraging pipeline and recent contract wins underpin organic growth which allied to a very strong base of contracted revenues puts the Group in a solid position to continue to deliver attractive shareholder returns.

 

Enquiries:

Redcentric plc Tel. +44 (0)845 034 1111

Tony Weaver, Chief Executive

Fraser Fisher, Chief Operating Officer

Tim Coleman, Chief Financial Officer

N+1 Singer - Nomad & Joint Broker Tel: +44 (0)20 7496 3000

Jonny Franklin-Adams / Ben Wright

 

finnCap - Joint Broker Tel: +44 (0)20 7220 0500

Charlotte Stranner / Stuart Andrews

 

MXC Capital Advisory LLP - Corporate Finance Adviser

Marc Young Tel. +44 (0)20 7965 8149

 

Newgate Threadneedle - Financial PR Tel. +44 (0)20 7653 9850

Josh Royston / Hilary Millar

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTWGUCCWUPCURU
Date   Source Headline
3rd Jun 20249:20 amRNSForm 8.5 (EPT/NON-RI)
31st May 202411:46 amRNSForm 8.5 (EPT/NON-RI)
31st May 20249:23 amPRNForm 8.3 - Redcentric Plc
30th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
30th May 202410:34 amRNSForm 8.5 (EPT/NON-RI)
30th May 20249:49 amPRNForm 8.3 - Redcentric Plc
29th May 20243:13 pmRNSForm 8.3 - Redcentric PLC
29th May 202411:43 amRNSForm 8.5 (EPT/NON-RI)
29th May 20249:30 amPRNForm 8.3 - Redcentric Plc
29th May 20247:00 amRNSForm 8.3 - Redcentric plc
28th May 20245:17 pmRNSForm 8.3 - Redcentric plc
28th May 20243:57 pmRNSForm 8.3 - Redcentric plc
28th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
28th May 20242:28 pmRNSSI Redstone LLP - Form 8.3 - Redcentric plc
28th May 20241:35 pmEQSForm 8.3 - Apex Fundrock Limited : Re Redcentric plc
28th May 20241:16 pmRNSForm 8.5 (EPT/NON-RI) - Amendment
28th May 202411:49 amRNSForm 8.3 - Redcentric plc
28th May 202411:06 amRNSForm 8.3 - Redcentric PLC
28th May 202410:24 amRNSForm 8.5 (EPT/NON-RI)
28th May 20249:56 amPRNCorrection: Statement regarding Redcentric plc ("Redcentric")
28th May 20249:13 amPRNStatement regarding Redcentric plc ("Redcentric")
24th May 20244:19 pmRNSResponse to press speculation
16th May 20247:00 amRNSTrading Update
14th May 20241:00 pmRNSExercise of Options
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.